Rising to the global challenge

46 million people worldwide are living with dementia. Roche and Genentech are working toward ending Alzheimer’s disease, the most common form of dementia.

By the numbers

2.3 million

people worldwide are affected by Multiple Sclerosis

The roles of B cells in MS

Recent clinical evidence suggests that B cells contribute to both the inflammatory and neurodegenerative aspects of the disease.